Study on Quantitative Diagnosis Model of TCM Syndromes of Post-Stroke Depression Based on Combination of Disease and Syndrome

注册号:

Registration number:

ITMCTR2100004285

最近更新日期:

Date of Last Refreshed on:

2020-10-19

注册时间:

Date of Registration:

2020-10-19

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

基于病证结合的中风后抑郁中医证候量化诊断模型研究

Public title:

Study on Quantitative Diagnosis Model of TCM Syndromes of Post-Stroke Depression Based on Combination of Disease and Syndrome

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于病证结合的中风后抑郁中医证候量化诊断模型研究

Scientific title:

Study on Quantitative Diagnosis Model of TCM Syndromes of Post-Stroke Depression Based on Combination of Disease and Syndrome

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2000039143 ; ChiMCTR2100004285

申请注册联系人:

杨继鹏

研究负责人:

杨继鹏

Applicant:

Jipeng Yang

Study leader:

Jipeng Yang

申请注册联系人电话:

Applicant telephone:

+86 13512213182

研究负责人电话:

Study leader's telephone:

+86 13512213182

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

516942713@qq.com

研究负责人电子邮件:

Study leader's E-mail:

516942713@qq.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

中国天津市南开区鞍山西道314号

研究负责人通讯地址:

中国天津市南开区鞍山西道314号

Applicant address:

314 Anshan Road West, Nankai District, Tianjin, China

Study leader's address:

314 Anshan Road West, Nankai District, Tianjin, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

天津中医药大学第一附属医院

Applicant's institution:

The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

TYLL2020[K]字022

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

天津中医药大学第一附属医院医学伦理委员会

Name of the ethic committee:

The Ethics Committee of the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2020/6/20 0:00:00

伦理委员会联系人:

范玉强

Contact Name of the ethic committee:

Yuqiang Fan

伦理委员会联系地址:

中国天津市南开区鞍山西道314号

Contact Address of the ethic committee:

314 Anshan Road West, Nankai District, Tianjin, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

天津中医药大学第一附属医院

Primary sponsor:

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

中国天津市南开区鞍山西道314号

Primary sponsor's address:

314 Anshan Road West, Nankai District, Tianjin, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

天津

市(区县):

Country:

China

Province:

Tianjin

City:

单位(医院):

天津中医药大学第一附属医院

具体地址:

南开区鞍山西道314号

Institution
hospital:

The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

Address:

314 Anshan Road West, Nankai District

经费或物资来源:

国家自然科学基金

Source(s) of funding:

National Natural Science Foundation of China

研究疾病:

中风后抑郁

研究疾病代码:

Target disease:

Post-Stroke Depression

Target disease code:

研究类型:

Study type:

诊断试验

Diagnostic test

研究设计:

Study design:

连续入组

Sequential

研究所处阶段:

Study phase:

回顾性研究

Retrospective study

研究目的:

基于病证结合的思想,在明确疾病的前提下对中风后抑郁不同病程下的证候要素进行提取,分析不同病程下中风后抑郁的主要证候分型及演变规律,建立统一、客观的中风后抑郁中医证候量化诊断模型,从而推动中风后抑郁中医证候诊断的标准化研究。

Objectives of Study:

This study is based on the idea of combination of disease and syndrome, using BP artificial neural network, the syndrome factors of depression after stroke in different course under the premise of clear disease under the extraction, analysis of main syndromes of depression after stroke in the different course type and evolution model of depression syndromes quantitative diagnosis of the establishment of a unified, guest the concept of depression after stroke, so as to promote the research of TCM syndrome diagnosis standard of stroke, improve the level of clinical diagnosis and treatment.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

①符合PSD诊断; ②年龄在18-75岁,男女均可; ③相关病例信息完整; ④脑卒中病程≥14天;

Inclusion criteria

1. Patients with PSD diagnosis; 2. Both male and female patients aged 18-75; 3. Patients with complete information of relevant cases; 4. Patients with stroke duration >= 14 days.

排除标准:

①伴意识障碍或明显的智力减退和失语的患者; ②具有阳性精神障碍个人史和家族史的患者; ③发病时有严重的心脏病、心功能不全、肝功能障碍、肾功能不全、呼吸衰竭、恶性肿瘤、消化道出血等预计不能完成长期随访的患者; ④妊娠和哺乳期妇女。

Exclusion criteria:

1. Patients with disturbance of consciousness or obvious mental retardation and aphasia; 2. Patients with positive personal and family history of mental disorders; 3. Patients with severe heart disease, cardiac insufficiency, liver dysfunction, renal insufficiency, respiratory failure, malignant tumor, gastrointestinal bleeding, etc. at the time of onset, who are not expected to complete long-term follow-up; 4. Pregnant and lactating women.

研究实施时间:

Study execute time:

From 2020-01-01

To      2022-12-31

征募观察对象时间:

Recruiting time:

From 2020-11-01

To      2021-10-31

诊断试验:

Diagnostic Tests:

金标准或参考标准(即可准确诊断某疾病的单项方法或多项联合方法,在本研究中用于诊断是否有该病的临床参考标准):

基于病证结合的中风后抑郁中医证候量化诊断模型研究

Gold Standard or Reference Standard (The clinical reference standards required to establish the presence or absence of the target condition in the tested population in present study):

美国卒中协会(ASA)医疗专业人员科学声明(2016)

指标试验(即本研究的待评估诊断试验,无论为方法、生物标志物或设备,均请列出名称):

基于病证结合的中风后抑郁中医证候量化诊断模型

Index test:

The American Stroke Association (ASA) medical Professionals Scientific Statement(2016)

目标人群(可以是某种疾病患者或正常人群,详细描述其疾病特征,注意应纳入符合分布特点的全序列病例,具有良好的代表性)

中风后抑郁患者

例数:

Sample size:

300

Target condition (The target condition is a particular disease or disease stage that the index test will be intended to identify. Please specify the characteristics in detail; the population should has a complete spectrum and good representative):

Quantitative Diagnosis Model of TCM Syndromes of Post-Stroke Depression Based on Combination of Disease and Syndrome.

容易混淆的疾病人群(即与目标疾病不易区分的一种或多种不同疾病,应避免采用正常人群对照的病例-对照设计):

例数:

Sample size:

0

Population with condition difficult to distinguish from the target condition, the normal population in a case-control study design should be avoid:

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

天津

市(区县):

Country:

China

Province:

Tianjin

City:

单位(医院):

天津中医药大学第一附属医院

单位级别:

三级甲等

Institution/hospital:

The First Affiliated Hospital of Tianjin University of traditional Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

中医证候评分量表记分

指标类型:

主要指标

Outcome:

Score of TCM syndrome score scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

西医理化检查

指标类型:

次要指标

Outcome:

physical and chemical examination of Western Medicine

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

性别

指标类型:

次要指标

Outcome:

Gender

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

切诊

指标类型:

主要指标

Outcome:

Palpating

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

闻诊

指标类型:

主要指标

Outcome:

Smelling

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

中药方剂原方名称

指标类型:

主要指标

Outcome:

Name of original prescription of traditional Chinese Medicine

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体重

指标类型:

次要指标

Outcome:

Weight

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

合并用药

指标类型:

次要指标

Outcome:

Combination therapy

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

望诊

指标类型:

主要指标

Outcome:

Inspection

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

问诊

指标类型:

主要指标

Outcome:

Inquiring

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

中风、PSD中医辨证分型

指标类型:

主要指标

Outcome:

TCM syndrome differentiation of Stroke and Post-Stroke Depression

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

年龄

指标类型:

次要指标

Outcome:

Age

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

病程

指标类型:

次要指标

Outcome:

Course of disease

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

既往史

指标类型:

次要指标

Outcome:

Past medical history

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 18
Min age years
最大 75
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

未涉及

Randomization Procedure (please state who generates the random number sequence and by what method):

Not covered

盲法:

未说明

Blinding:

Not stated

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

Not stated 请阅读网页注册指南中关于“原始数据共享”的内容。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Not stated

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Not stated

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Not stated

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above